Trends in Cell Biology
ReviewEMT Transition States during Tumor Progression and Metastasis
Section snippets
EMT Transition States
Epithelial–mesenchymal transition (EMT) is a cellular process in which cells lose their epithelial characteristics and acquire mesenchymal features. EMT has been associated with various tumor functions, including tumor initiation, malignant progression, tumor stemness, tumor cell migration, intravasation to the blood, metastasis, and resistance to therapy 1, 2, 3. EMT has long been viewed as a binary process with two distinct cell populations, epithelial and mesenchymal 1, 4, and is often
EMT in Mouse Cancer Models
Until recently, most studies on EMT were performed using cancer cell lines in vitro or by assessing pathological specimens of human cancers, precluding the assessment of the functional significance and the cellular plasticity of EMT in vivo. Moreover, due to the lack of expression of epithelial markers in full EMT, it is difficult to determine with high confidence whether cells expressing only mesenchymal markers correspond to tumor cells or to cancer associated fibroblasts. For these reasons,
EMT Transition States In Vivo
In HF derived SCCs presenting features of carcinosarcoma, EpCAM is expressed in a bimodal pattern in YFP+ tumor cells, suggesting that EMT may occur as a binary switch. However, a screen of a large panel of cell surface markers performed in these tumors revealed that EpCAM− mesenchymal tumor cells were heterogeneous and expressed different levels of the cell surface markers CD106, CD61 and CD51 [9]. Combinatorial multicolor FACS analysis revealed that EpCAM− mesenchymal tumor cells could be
Stemness and Plasticity of EMT Transition States
Cancer stem cells describe a population of tumor cells with increased tumorigenic potential that self-renew and differentiate into different types of tumor cells present in primary tumors. Cellular assays, including tumor transplantation, lineage tracing, and lineage ablation have been developed to assess tumor stemness [48]. EMT has been associated with tumor stemness by their increased tumor propagating potential following their transplantation into immunodeficient mice. Forced expression of
EMT Transition States and Metastasis
The role of EMT in metastasis has been recently debated and there are cancers that seem to metastasize without EMT. EMT was initially shown to promote metastasis by the demonstration that Twist1 silencing in breast cancer cell lines decreases lung metastasis [55]. In contrast, it was suggested that EMT was dispensable for metastasis due to the presence of metastasis in a mouse model of pancreatic tumors in which either Twist1 or Snai1 were deleted [56], or in a mouse mammary tumor model with
Microenvironment Associated with EMT Transition States
The phenotypic plasticity by which epithelial tumor cells that initially undergo EMT are able to revert to epithelial phenotype by MET at the distant site has been suggested to be regulated by the microenvironment [2]. Supporting this hypothesis, the different EMT populations are localized in distinct tumor regions associated with particular microenvironment in skin SCC and mammary tumors [9]. The composition of the different stromal components changes as tumor cells progress towards EMT, with
Gene Regulatory Network of EMT Transition States
The different EMT transitional states are associated with changes in the chromatin and transcriptional landscape of the cells that are mediated by gene regulatory networks (GRNs) that control the gene expression program specific of each state. Recent progresses have been made to define the enhancer logic and GRN that control the different EMT states.
Chromatin profiling using assay for transposase-accessible chromatin using sequencing (ATAC-seq) in HF derived SCCs combined with transcriptional
Concluding Remarks
The studies summarized in this review demonstrate that EMT is not a binary process, and different tumor cell populations presenting different degrees of EMT can be found in different cancers. These different populations present different functional properties and the hybrid EMT state is associated with increased metastatic potential.
Despite the progresses in the identification of the different EMT states and understanding the mechanisms regulating cell fate transition in tumors, there are still
References (115)
EMT: 2016
Cell
(2016)Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
Mod. Pathol.
(2006)Next-generation sequencing analysis identifies genomic alterations in pathological morphologies: a case of pulmonary carcinosarcoma harboring EGFR mutations
Lung Cancer
(2018)Epithelial paradox: clinical significance of coexpression of E-cadherin and vimentin with regard to invasion and metastasis of breast cancer
Clin. Breast Cancer
(2018)EMT and dissemination precede pancreatic tumor formation
Cell
(2012)Mesenchymal cancer cell-stroma crosstalk promotes niche activation, epithelial reversion, and metastatic colonization
Cell Rep.
(2015)The epithelial-mesenchymal transition generates cells with properties of stem cells
Cell
(2008)Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
Cell
(2004)Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1
Cancer Cell
(2012)Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis
Cancer Cell
(2012)
EMT 2.0: shaping epithelia through collective migration
Curr. Opin. Genet. Dev.
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis
Cell
Collective invasion in breast cancer requires a conserved basal epithelial program
Cell
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis
Cancer Cell
Circulating tumor cells as a window on metastasis biology in lung cancer
Am. J. Pathol.
KRAS and YAP1 converge to regulate EMT and tumor survival
Cell
To differentiate or not – routes towards metastasis
Nat. Rev. Cancer
Regulatory networks defining EMT during cancer initiation and progression
Nat. Rev. Cancer
Oncogenic roles of EMT-inducing transcription factors
Nat. Cell Biol.
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to E-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
Cell Death Dis.
TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops
Sci. Signal.
An Ovol2-Zeb1 mutual inhibitory circuit governs bidirectional and multi-step transition between epithelial and mesenchymal states
PLoS Comput. Biol.
Stability of the hybrid epithelial/mesenchymal phenotype
Oncotarget
Identification of the tumour transition states occurring during EMT
Nature
Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer
Cell Cycle
Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior
Am. J. Pathol.
Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface
J. Pathol.
Wilms’ tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma
PLoS One
Molecular portraits of epithelial, mesenchymal, and hybrid states in lung adenocarcinoma and their relevance to survival
Cancer Res.
Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype
J. Biomed. Sci.
Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses
Cancer Res.
Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity
PLoS One
Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients
Clin. Cancer Res.
Clinical significance of E-cadherin and vimentin co-expression in breast cancer
Int. J. Oncol.
Morphological and immunohistochemical identification of epithelial-to-mesenchymal in clinical prostate cancer
Oncotarget
Tumor budding: the name is EMT. Partial EMT
J. Clin. Med.
Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients
PLoS One
Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulated
BMC Cancer
Survival outcomes in cancer patients predicted by a partial EMT gene expression
Cancer Res.
The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study
Am. J. Surg. Pathol.
Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases
Arch. Pathol. Lab. Med.
Pulmonary carcinosarcoma: immunohistochemical and ultrastructural studies
Pathol. Int.
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype
Cancer Res.
Carcinosarcoma of the esophagus with rapid morphological change
Am. J. Gastroenterol.
Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing
Virchows Arch.
Cutaneous carcinosarcoma and the EMT: to transition, or not to transition? That is the question
Virchows Arch.
Carcinosarcomas: tumors in transition?
Histol. Histopathol.
Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines
Oncotarget
Stemness of the hybrid epithelial/mesenchymal state in breast cancer and its association with poor survival
PLoS One
Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer
Cell
Cited by (1725)
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer
2024, Translational OncologyNatural compound Byakangelicin suppresses breast tumor growth and motility by regulating SHP-1/JAK2/STAT3 signal pathway
2024, Biochemical and Biophysical Research Communications